Related Experiment Video
Updated: Jan 15, 2026

11:20
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
11.3K
Estimating Tumor Proportion in Smear Slides for Reliable Molecular Analysis
Cisel Aydin Mericoz1, Ibrahim Kulac1, Pinar Firat1
1Department of Pathology, School of Medicine, Koç University, ISTANBUL, TÜRKİYE.
Turk Patoloji Dergisi
|October 8, 2025
Summary
Tumor cell percentage estimation in cytological smears shows variability among pathologists. Standardized protocols are needed for reliable molecular testing, especially in borderline cases.
Area of Science:
- Cytopathology
- Molecular Pathology
- Oncology Diagnostics
Background:
- Molecular pathology is crucial for cancer diagnostics and theranostics.
- Cytological smears are increasingly used for molecular testing.
- Accurate tumor cell percentage estimation is vital for reliable molecular test results.
Purpose of the Study:
- To evaluate the reliability of tumor cell percentage estimations among different pathology specialists.
- To compare the consistency of estimations by an expert cytopathologist, a molecular cytopathologist, and a molecular pathologist.
Main Methods:
- Digital images of May-Grünwald-Giemsa stained mediastinal lymph node smear slides were used.
- Three pathologists independently estimated tumor cell percentages in predefined categories.
- Manual cell counting served as the gold standard for comparison.
Main Results:
- The molecular cytopathologist demonstrated the highest consistency (Kappa = 0.69), followed by the expert cytopathologist (Kappa = 0.64).
- The molecular pathologist showed moderate consistency (Kappa = 0.52).
- Agreement was highest in the 71-100% category, but tumor proportions were often overestimated in the 11-20% category.
Conclusions:
- Variability in tumor percentage estimation necessitates standardized protocols and training.
- Substantial agreement was achieved in certain categories, but discrepancies in borderline cases require attention.
- Further research is needed to enhance tumor cell estimation methods for molecular pathology.

